[Thiazolidinediones and insulin sensitivity].
Pégorier
J-P
JP
Institut Cochin, département d'Endocrinologie, INSERM U 567, CNRS UMR 8104, Université Paris V René Descartes, 24, rue du Faubourg Saint Jacques, 75014 Paris, France. pegorier@cochin.inserm.fr
Girard
J
J
D003920:Diabetes Mellitus / Q000188:drug therapy / Q000503:physiopathology; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology*; D045162:Thiazolidinediones / Q000494:pharmacology*; D014157:Transcription Factors / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D007328:Insulin; D018160:Receptors, Cytoplasmic and Nuclear; D045162:Thiazolidinediones; D014157:Transcription Factors; D014409:Tumor Necrosis Factor-alpha